Counting the uncounted: a nationwide look at two rare epilepsies
NCT ID NCT06395792
First seen Aug 17, 2026 · Last updated Aug 18, 2026 · Updated 1 time
Summary
This observational study aims to measure how many people in Portugal have Dravet syndrome (DS) or Lennox-Gastaut syndrome (LGS), two rare and severe forms of epilepsy. Researchers will review existing medical records from about three public hospitals to estimate the percentage of people diagnosed in 2022 and newly diagnosed in 2021 and 2022. They will also break down the numbers by age group (children, teenagers, adults) and gather extra details about diagnosis patterns. No personal information is collected, and no treatment is given.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- This study could provide a clearer picture of how many people in Portugal live with these rare epilepsy syndromes, helping to plan healthcare resources and support services.
- What could go wrong
- Because it only looks at hospital records from a few sites, the numbers may not fully represent the entire country, and the study does not test any treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Expected to start
-
Dec 2024
An estimate. Start dates often move.
- Expected to finish
-
Jul 2025
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants diagnosed with DS or LGS at public hospitals in Portugal will be enrolled in the study.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Diagnosis criteria for DS: • All the following criteria must be met: i. Seizures onset within 1-20 months (usually within the first year of life). ii. Normal initial development prior to presentation (no cognitive or behavioural disability before the onset of seizures) followed by behaviour and cognitive impairment. iii. Recurrent focal clonic (hemiclonic) febrile and afebrile seizures (which often alternate sides from seizure to seizure), focal to bilateral tonic-clonic, and/or generalized clonic seizures. • And at least one of the following criteria must be met: i. Emergence of other seizure type, including atypical absence seizures, myoclonic seizures, atonic seizures, or non-tonic-clonic status epilepticus between 1-4 years. ii. Seizures triggered by fever due to illness or vaccinations, hot baths, sudden temperature changes, high level of activity, or by strong lighting or exposure to certain visual patterns. iii. Mutations or copy number variants in the SCN1A gene. 2. Diagnosis criteria for LGS: Given the uncertainties associated with the diagnosis of this condition, two different criteria will be used, a stricter criterion, intended to identify "pure" Lennox-Gastaut syndrome participants, and a wider criterion, intended to also include the so-called Lennox-Gastaut-like participants. Lennox-Gastaut syndrome - stricter criteria: • All the following criteria must be met: i. Seizures onset before 18 years of age, typically from 1 to 8 years. ii. Progressive development/cognition impairment after seizures onset. iii. Tonic seizures. iv. At least one additional seizure: generalised tonic-clonic seizures, atypical absence seizures, atonic seizures, myoclonic seizures, focal impaired awareness, epileptic spams, or non-convulsive status epilepticus v. Slow (less thank \[\<\] 2.5 hertz \[Hz\]) spike-and-wave EEG pattern. vi. Paroxysmal fast activity (10 Hz or greater) in sleep. Lennox-Gastaut syndrome - wider criteria: * At least one the following criteria must be met: i. Tonic seizures. ii. Multiple types of seizures, including generalised tonic-clonic seizures, atypical absence seizures, atonic seizures, myoclonic seizures, myoclonic-atonic seizures, focal seizures, epileptic spams, or nonconvulsive status epilepticus. * And at least one the following criteria must be met: i. Slow (\<2.5 Hz) spike-and-wave EEG pattern. ii. Paroxysmal fast activity (10 Hz or greater) in sleep. * And at least two of the following criteria must be met: i. Seizures onset before 18 years of age, typically from 1 to 8 years. ii. Progressive development/cognition impairment after seizures onset. iii. Development/cognition impairment starts prior to seizures onset. iv. History of Infantile epileptic spasms syndrome (IESS), West or Ohtahara syndromes. Exclusion Criteria 1. Has epileptic condition other than DS or LGS. 2. Has DS or LGS not residents in the reference area of the hospital.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dravet syndrome (DS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an experimental drug cut drop seizures in a severe childhood epilepsy?
- Can a new drug tame seizures in two severe epilepsy syndromes?
- Can a new Add-On drug tame seizures in dravet syndrome?
- Blood markers may expose hidden brain changes in dravet syndrome
- How many people live with rare epilepsies in spain? a nationwide count aims to find out
- Gene therapy hopes to tame severe childhood epilepsy